These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 6154517

  • 21. Tumour markers in testicular tumours.
    Chisholm GD.
    Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
    [No Abstract] [Full Text] [Related]

  • 22. The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
    Scardino PT, Cox HD, Waldmann TA, Mcintire KR, Mittemeyer B, Javadpour N.
    J Urol; 1977 Dec; 118(6):994-9. PubMed ID: 72833
    [No Abstract] [Full Text] [Related]

  • 23. Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors.
    Lange PH, Fraley EE.
    Urol Clin North Am; 1977 Oct; 4(3):393-406. PubMed ID: 76357
    [No Abstract] [Full Text] [Related]

  • 24. Urinary gonadotropins in management and prognosis of testicular tumor.
    Keogh B, Hreshchyshyn MM, Moore RH, Merrin CE, Murphy GP.
    Urology; 1975 Apr; 5(4):496-503. PubMed ID: 1168960
    [Abstract] [Full Text] [Related]

  • 25. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
    Javadpour N, McIntire KR, Waldmann TA, Bergman SM.
    J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391
    [No Abstract] [Full Text] [Related]

  • 26. Molecular heterogeneity of chorionic gonadotropin in some testicular cancer patients.
    Light PA, Foster JP, Felton T, Eckert H, Tovey KC.
    Lancet; 1983 Jun 04; 1(8336):1284. PubMed ID: 6134082
    [No Abstract] [Full Text] [Related]

  • 27. Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors.
    Cochran JS, Walsh PC, Porter JC, Nicholson TP, Peters PC.
    Surg Forum; 1974 Jun 04; 25(0):542-3. PubMed ID: 4474717
    [No Abstract] [Full Text] [Related]

  • 28. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
    Schultz H, Sell A, Nørgaard-Pedersen B, Arends J.
    Cancer; 1978 Nov 04; 42(5):2182-6. PubMed ID: 82474
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of serum AFP, HCG, and CEA in testicular tumor].
    Miki T, Oda H, Kamei O, Saiki S, Kinouchi T, Kuroda M, Yoshida M, Kiyohara H, Usami M, Osafune M.
    Nihon Hinyokika Gakkai Zasshi; 1983 Jul 04; 74(7):1236-47. PubMed ID: 6198548
    [No Abstract] [Full Text] [Related]

  • 30. [Clinical use of alpha fetoproteins (AFP) and choriogenic gonadotropins (CGT) in terminal testicular tumors].
    Vopr Onkol; 1979 Jul 04; 25(9):111-2. PubMed ID: 90428
    [No Abstract] [Full Text] [Related]

  • 31. Re: alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Javadpour N.
    J Urol; 1978 Mar 04; 119(3):422-3. PubMed ID: 76688
    [No Abstract] [Full Text] [Related]

  • 32. Human chorionic gonadotropin in seminoma.
    Javadpour N.
    J Urol; 1984 Feb 04; 131(2):407. PubMed ID: 6199523
    [No Abstract] [Full Text] [Related]

  • 33. Tumor markers in testicular cancer--an update.
    Javadpour N.
    Prog Clin Biol Res; 1985 Feb 04; 203():141-54. PubMed ID: 2421328
    [No Abstract] [Full Text] [Related]

  • 34. [Pregnancy-specific beta 1-glycoprotein: a tumor marker].
    Horne CH, Bremner RD.
    Ric Clin Lab; 1984 Feb 04; 14 Suppl 2():33-8. PubMed ID: 6085182
    [No Abstract] [Full Text] [Related]

  • 35. [Diagnostic and prognostic value of biologic markers in testicular cancer].
    Barrelet L, Dialdas J, Chapuis B.
    Rev Med Suisse Romande; 1980 Sep 04; 100(9):741-8. PubMed ID: 6161405
    [No Abstract] [Full Text] [Related]

  • 36. [Study of various markers (alpha fetoprotein, chorionic gonadotropin, lactate dehydrogenase) during chemotherapy of malignant testicular tumors].
    Lichinitser MR, Bassalyk LS, Levina DM, Pashintseva LP, Molodyk AA.
    Ter Arkh; 1984 Sep 04; 56(6):77-9. PubMed ID: 6206585
    [No Abstract] [Full Text] [Related]

  • 37. The value of biologic markers in diagnosis and treatment of testicular cancer.
    Javadpour N.
    Semin Oncol; 1979 Mar 04; 6(1):37-47. PubMed ID: 88072
    [No Abstract] [Full Text] [Related]

  • 38. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
    Lippert MC, Javadpour N.
    Cancer; 1981 Nov 15; 48(10):2274-8. PubMed ID: 6170417
    [Abstract] [Full Text] [Related]

  • 39. Rapid diagnosis of testicular choriocarcinoma by urinary pregnancy tests.
    Caulfield MJ, Dilkes MG, Iles RK, Handel BT, Oliver RT.
    Lancet; 1990 May 19; 335(8699):1230. PubMed ID: 1971080
    [No Abstract] [Full Text] [Related]

  • 40. Improved staging for testicular cancer using biologic tumor markers: a prospective study.
    Javadpour N.
    J Urol; 1980 Jul 19; 124(1):58-9. PubMed ID: 6157840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.